Sun Pharma to buy U.S. drug firm Concert for $576 mn
The upfront payment of $8 per share of common stock in cash represents a premium of around 33% to Concert's 30-day volume weighted average price as of January 18, 2023.
sun pharmaceutical industries
January 2023
December 2022
September 2022
January 2022
Sun Pharma launches generic version of Pfizer's blockbuster cancer drug
The price of the palbociclib treatment, which used to be at least ₹50,000 a month, will come down substantially.
Sun Pharma gets U.S. FDA warning for Halol facility; share falls 2%
The pharma company received a warning letter from the U.S. FDA for violations of manufacturing standards at the Halol facility in Gujarat.
Shanghvi's Silent 'Sun' Rise
Acquisitions and product focus make Shanghvi India's wealthiest drug maker.
Sensex surges 672 pts as New Year euphoria continues, Nifty reclaims 17,800; RIL, SBI, Titan lead gain
The BSE Sensex and the NSE Nifty ended more than 1% higher on Tuesday, led by index heavyweights such as RIL, SBI, Titan, and NTPC.
